NYSE:EQD Equity Distribution Acquisition (EQD) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free EQD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.01▼$10.0350-Day Range$9.98▼$10.0252-Week Range$9.78▼$10.03Volume214,959 shsAverage Volume74,440 shsMarket Capitalization$518.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Equity Distribution Acquisition alerts: Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> About Equity Distribution Acquisition Stock (NYSE:EQD)Equity Distribution Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities. Equity Distribution Acquisition Corp. was incorporated in 2020 and is based in Chicago, Illinois.Read More Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> EQD Stock News HeadlinesApril 7, 2024 | finance.yahoo.comPetalfast Continues National Expansion With Acquisition of Flow Distribution, Arizona’s Largest Cannabis DistributorJanuary 18, 2024 | businesswire.comRegulatory Compliance Solution Provider Ascent Technologies Acquired by Private Equity Firm Edgewater Equity PartnersMay 8, 2024 | Behind the Markets (Ad)Could this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.December 12, 2023 | markets.businessinsider.comEQS-News: SGT German Private Equity updates guidance for 2023November 4, 2023 | investing.comEQD_u Historical DataNovember 1, 2023 | benzinga.comEquity Group Investments Partners with CraneWorks to Further Fuel GrowthSeptember 21, 2023 | finance.yahoo.comCoho Announces Amended Terms for Acquisition of Purebread and Equity FinancingSeptember 5, 2023 | investing.comBnp Paribas Funds Russia Equity Classic Distribution (0P000102Q4)May 8, 2024 | Behind the Markets (Ad)Could this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.July 19, 2023 | technews.tmcnet.comAudax Private Debt Provides Financing to Support Incline Equity Partners' Acquisition of GME Supply Co.July 14, 2023 | bloomberg.comEQT’s Sinding Doubles Down on Private Equity, Shuns Credit CrazeMay 26, 2023 | benzinga.comGlobal Equity Indexed Life Insurance Market Report 2023: Increasing Access to Insurance Products and Services Bolsters GrowthMay 12, 2023 | investing.comEquity Distribution Acquisition Corp (EQD)April 25, 2023 | ca.finance.yahoo.comKENSINGTON PRIVATE EQUITY FUND ANNOUNCES NEW DISTRIBUTIONMarch 1, 2023 | ecampusnews.comThesis Announces Acquisition and Growth Investment by SilverTree EquityFebruary 10, 2023 | investopedia.comCost of Equity Definition, Formula, and ExampleJanuary 29, 2023 | thestreet.comWhy Private Equity Firms Are Having Trouble Winning Health Care DealsJanuary 12, 2023 | thestreet.comUkraine Standoff Spotlights Energy Transfer Equity's LNG ProspectsDecember 20, 2022 | yahoo.comAmerican Equity Rejects Unsolicited Acquisition Proposal from Prosperity Group Holdings LP and Elliott Investment Management L.P.September 22, 2022 | cnet.comBest Ways to Use Your Home Equity for Remodeling ProjectsSeptember 15, 2022 | dailymail.co.ukEquity ReleaseSeptember 11, 2022 | reuters.comEquity Distribution Acquisition CorpAugust 10, 2022 | apnews.comNYSE to Suspend Trading Immediately in Warrants of Equity Distribution Acquisition Corp. (EQD WS) and Commence Delisting ProceedingsAugust 10, 2022 | finance.yahoo.comBillionaire Sam Zell-Backed SPAC to Return Cash to InvestorsAugust 9, 2022 | finance.yahoo.comSPAC Equity Distribution Acquisition Corp. to redeem its shares, liquidateJuly 7, 2022 | nasdaq.comThis REIT's Expansion Strategy Could Pay Big DividendsJuly 6, 2022 | uk.finance.yahoo.comEquity Distribution Acquisition Corp. (EQD)See More Headlines Receive EQD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Equity Distribution Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorUnclassified Industry Holding & Other Investment Offices Sub-IndustryN/A Current SymbolNYSE:EQD CUSIPN/A CIK1818221 Webequitydac.com Phone312-454-0100FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$19.60 million Net MarginsN/A Pretax MarginN/A Return on Equity-82.70% Return on Assets5.31% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.19 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.38 per share Price / Cash Flow26.46 Book Value($0.60) per share Price / Book-16.70Miscellaneous Outstanding Shares51,750,000Free FloatN/AMarket Cap$518.54 million OptionableNot Optionable Beta-0.04 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. William A. Galvin (Age 59)CEO & Director Mr. Philip G. Tinkler (Age 58)Chief Financial Officer Mr. Joseph Miron (Age 53)Sec. Key CompetitorsPrimavera Capital AcquisitionNYSE:PVNabors Energy Transition Corp. IINASDAQ:NETDFusion Acquisition Corp. IINYSE:FSNBAres Acquisition Co. IINYSE:AACTRigel Resource AcquisitionNYSE:RRACView All Competitors This page (NYSE:EQD) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equity Distribution Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
